Patient-Reported Symptom Burden and Supportive Care Needs of Patients With Stage II-III Colorectal Cancer During and After Adjuvant Systemic Treatment: A Real-World Evidence Study

PURPOSE: Patients with colorectal cancer (CRC) experience a range of physical and psychologic symptoms, and supportive care needs throughout the illness trajectory. We used patient-reported outcomes and administrative health data to describe symptom burden and supportive care needs during and after adjuvant treatment and determine factors associated with changes to symptom burden. METHODS: A…

Read the full article here

Source: JCO Oncology Practice

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: CRCSM, PRO

Tweets with this article

JCO Oncology Practice

Longitudinal #PRO symptom burden & supportive care needs in pts w/ #CRCsm during and after adjuvant tx show sx severity was generally low & most sx remained stable or improved after tx, but certain pts were more likely to have severe/persistent sx. ➡️ https://t.co/dp0tMS4kg5 https://t.co/csgpWURMar

Publications Lounge | ASCO Annual Meeting

Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve…

June 5, 2023

Publications Lounge | ASCO Annual Meeting

Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve…

June 3, 2023

ASCO 2023 Publications Lounge Mentoring

Please review the available slots below and click on the button to sign up (all times shown in Central Time). You may sign up for…

May 26, 2023

Optimizing and Refining Immunotherapy in Breast Cancer

Despite a rocky start in breast cancer, immune checkpoint inhibitors (ICIs) have now made their way into clinical practice.1 As noted in the review article…

January 20, 2023

Role of Immunotherapy in Breast Cancer

The advent of immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized the treatment of solid tumor malignancies. In breast cancer, the most robust data to…

January 19, 2023

Competitive Funding Strategies for the Conquer Cancer Foundation of ASCO

Purpose: The Conquer Cancer Foundation (CCF), the philanthropic arm of ASCO, is responsible for funding innovative clinical research. CCF wants to broaden its donor base…

Mike Thompson, MD, PhD, FASCO January 17, 2023

Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the Ovary

Ovarian cancer is the most common cause of mortality in patients with gynecologic malignancies. Advanced-stage high-grade serous carcinoma accounts for most ovarian cancer cases. Current…

January 17, 2023

Related Articles